Merck & company inc

Major-Pharmaceuticals

MRK


2000 Galloping Hill Road
Kenilworth , NJ 07033

Executive/
Director

Price

  • Last Close
  • $ 99.15
    $ -0.03 -0.03 %
    Jan 3, 2025
  • 52-Week High/Low
  • $133.1 - $100.17
  • YTD
  • -0.3%

  • Trading Volume
  • 230,819
  • Market Cap Full
  • $ 251.2B
  • Shares Outstanding
  • 2534M
    Oct 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 1% 8.7% -2.4% 8.9% -5% -5.5% 7.1% -4.1% 21% -0.3%
Q2 9.8% 1.6% 14.8% 0.3% 4% 0.6% 11.1% 8.5% -0.4% -
Q3 9.1% 0.6% 18.2% 0.5% 8% -3.4% -5.5% -10.7% 4% -
Q4 -5% -12.1% 7.6% 7.1% -1.4% 2% 28.8% 6.3% -1.7% -
J F M A M J J A S O N D
2025 -0.3% - - - - - - - - - - -
2024 10.7% 5.3% 3.8% -3.8% -1% 3.7% -13.4% 4% - - - -2.1%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -4%15%-1%40%18%-10%-6%45%-2%-9%-0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.89 0.88 0.27 1.12 1.26 1.25 1.7 1.11
Q2 0.93 1.01 0.63 1.03 1.18 0.61 1.55 -2.35
Q3 1.07 1.11 0.73 0.74 1.16 1.8 1.28 1.86
Q4 0.89 0.98 0.69 0.92 -0.83 1.48 1.18 -
A 3.8 4 2.3 3.8 2.8 5.1 5.7 0.62

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2020 2021 2022 2023 2024 2025
Q1 0.61 0.65 0.69 0.73 0.77 0.81
Q2 0.61 0.65 0.69 0.73 0.77 -
Q3 0.61 0.65 0.69 0.73 0.77 -
Q4 0.61 0.65 0.69 0.73 0.77 -
A 2.44 2.6 2.76 2.92 3.08 0.81
2018 2019 2020 2021 2022 2023
Mar - 2581.2 2536.3 2530.3 2527.7 2538.6
Jun 2690.3 2574.6 2524.1 2532.1 2528.8 2537.4
Sep 2659.5 2560.4 2529.2 2531.4 2533.3 2537.5
Dec 2600.4 2546 2530 2525.9 2535.4 2534

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 3 2.3 2.5 2.4 2.5
Fixed Asset Turnover 1.9 1.6 1.7 2 1.6
Total Asset Turnover 0.5 0.5 0.5 0.6 0.5
Leverage
Debt Ratio 0.8 1 0.9 0.8 0.8
Debt – Equity Ratio 0.6 0.8 1 0.9 0.7
Interest Coverage 4.9 88 6 5.1 3.3
Equity multiplier 0.7 0.8 1.1 0.9 1